Clinical Trials
8 trialsNCT01332617 2017-12-29
Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
University of Louisville
Phase 2 Withdrawn
NCT00577642 2017-03-10
Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
Massachusetts General Hospital
Phase 2 Completed
NCT00083382 2015-06-24
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
University of Arkansas
Phase 2 Completed
NCT00972959 2014-08-05
Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy
University of Athens
Phase 2 Completed
NCT00760370 2011-12-07
Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
Vejle Hospital
Phase 2 Completed
NCT00263484 2011-07-21
dtZ
Gleneagles Hospital
Phase 2 Completed
NCT00216151 2011-05-02
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma
Hoosier Cancer Research Network
Phase 2 Terminated
NCT01341262 2011-04-25
THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Completed